Skip to content
Screener

Teladoc Health TDOC Q1 2026 earnings

Reported April 29, 2026 · After market close

Revenue$613.8MBeat by $2.8M
EPS-$0.36Miss by $0.01
Revenue estimate$611.0M
EPS estimate-$0.35

Next report

Oct 28, 2026 (in a month)
Revenue estimate$590.3M
EPS estimate-$0.23

Financials

Q1 2026

Income statement

See full
Revenue$613.8M-2.5%
Gross profit$416.3M-3.8%
Operating income-$61.8M+48.8%
Net income-$63.8M+31.4%
EPS (diluted)-$0.36+32.1%

Balance sheet

See full
Cash & equivalents$750.7M-37.1%
Total debt$42.2M-92.9%
Total equity$1.3B-6.4%
Total assets$2.8B-18.5%

Cash flow

See full
Operating cash flow$9.5M-40.2%
CapEx$1.7M-39.1%
Free cash flow$7.9M-40.5%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$972.26M-29.7%
Enterprise value$263.76M-66.3%
P/S0.4×-0.2×

Profitability

See full
Gross margin69.3%-1.2pp
Operating margin-8.1%-3.6pp
Net margin-6.8%-3.1pp
FCF margin11.1%-0.2pp

Returns & leverage

See full
Return on equity-12.4%-5.4pp
Debt / equity0×-0.4×
Current ratio2.8×+1.1×

Segments

By segment

See full
Integrated Care$395.4M+1.5%
BetterHelp$218.4M-9.0%

By product

See full
Access Fees$484.7M-7.8%
Other$129.2M+24.7%

FAQ

When did Teladoc Health report Q1 2026 earnings?
Teladoc Health (TDOC) reported Q1 2026 earnings on April 29, 2026 after market close.
What were Teladoc Health's Q1 2026 revenue and EPS?
Teladoc Health reported revenue of $613.8M and eps of $-0.36 for Q1 2026.
Did Teladoc Health beat estimates in Q1 2026?
Revenue beat the consensus estimate of $611.0M by $2.8M. EPS missed the consensus estimate of $-0.35 by $0.01.
How did Teladoc Health's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 2.5% from $629.4M a year earlier and eps declined 89.5% from $-0.19.
Where can I find Teladoc Health's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001477449-26-000026) and the 10-Q periodic report (0001477449-26-000028) directly on SEC EDGAR. The filing index links above go to sec.gov.